روشن امکانات کی شاعرہ: فضا موسیٰ
ڈاکٹر رحمت علی شادؔ
ہجر اثاثہ رہ جائے گا درد خلاصہ رہ جائے گا
شعر نگر میں نام ہمارا اچھا خاصا رہ جائے گا
شہرِ فرید میں جنم لینے والی ایک نو عمر، دوسروں سے ذرا ہٹ کر سوچنے والی، عام لوگوں سے قدرے مختلف مگر سنجیدہ، ہونہار، باشعور اور روشن امکانات کی ابھرتی ہوئی شاعرہ فضاؔ موسیٰ پاک پتن کی شعری فضا میں ایک خوش گوار اور کیف پرور جھونکے سے کسی طرح کم نہیں ان کا تازہ شعری مجموعہ’’ فضا سے کہنا‘‘ منصہ شہود پر آنے کے لیے بے قرار ہے۔ ان کا کلام پڑھنے کے بعد راقم اس نتیجے پر پہنچا ہے کہ ان کی غزلیات کے کچھ مصرعے اور اشعار اپنے تیکھے پن، ندرتِ خیال، پختگی فکر ، داخلیت اور خارجیت سے بھرپور رومانوی انداز لیے چونکا دینے کے ساتھ ساتھ دعوتِ فکر دیتے ہوئے نظر آتے ہیں۔
فضاؔ موسیٰ عہدِ جدید کی ایک منفرد لب و لہجے کی حامل شاعرہ ہیں جنھوں نے بالکل تھوڑے عرصے میں اپنی ذہنی اپج سے پاک پتن کی ادبی فضا میں اپنی نمایاں انفرادیت اور اپنا شعری تشخص قائم کیا ہے۔رومانوی فضائوں میں فضا کی شاعری عشق و محبت کی داستان لیے اپنی تمام تر رعنائیوں اور لوازمات کے ساتھ جلوہ گر ہے۔ ان کی غزلیات میں محبت کے مختلف رنگ جا بجا بکھرے نظر آتے ہیں، کبھی کبھی یوں محسوس ہوتا ہے کہ وہ زندگی کے کئی رازوں سے آشنا ہیں اور اس طرح وہ اپنے باطنی احساسات و جذبات کو حقیقت کا روپ دینے پر قادر نظر آتی ہیں۔ عشق و محبت کے کئی کئی رنگ ان کے کلام کا جزو لا ینفک ہیں۔ محبت اور محبت کے رنگوں کے متعلق وہ لکھتی ہیں:
جینے کا سامان محبت گر بخشے مسکان محبت
ساتوں رنگ ہیں اس دنیا...
Ashaykh Mahmūd bin Abī Bakr bin Abīulala bin Alī Al-bukhārī Al-kalābādhī is one of scholars of Mirāth. He was born in 644 A.H. And died in 700 A.H. He was a man of eminence in Central Asia. He visited many metropolitan cities across the world to get knowledge. During his foreign visits, he contacted great scholars of Islamic sciences. Similarly, thousands of students used to attend his lectures. Allāmah Kalābādhī was a man of letters. He wrote many books. Famous of them are: Ḥall ul Frāi Fī Sharah Naẓm Assirājiyah, Ḍaw us Sirāj Fī Sharah Assirājiyah, Mushtabeh un Nasab Fī Asmā ur Rijāl, Mujamush Shuyūkh, Al Minhāj Al Muntakhab.
Background: Diarrhoeal disease is the second most common cause of death in children under 5 years of age in Kenya. Treatment with Oral Rehydration Solution (ORS), elemental zinc and continued feeding (as recommended by the World Health Organisation) led to a significant reduction in mortality in the 1970s and 1980s, which has slowed since then. Adjunctive treatments have however, not gained much popularity either due to modest improvements in morbidity and mortality or unacceptable adverse effect profiles. Racecadotril, an enkephalinase inhibitor, has been used for over 2 decades in parts of Europe but is only recently gaining recognition in other parts of the world. No trials have been done testing its efficacy compared with the standard treatment recommended by the WHO (i.e. the combination of ORS and Zinc). This study aimed to measure the efficacy of racecadotril in the treatment of acute severe gastroenteritis disease in children admitted to hospital and on zinc. Objectives: The primary objective was to compare the number of stools in the first 48 hours in children admitted with severe acute gastroenteritis treated with either Racecadotril or placebo. The secondary objectives were: to study the impact of Racecadotril on duration of inpatient stay as well as duration of illness in children admitted with severe acute gastroenteritis, and to describe the side effect profile of Racecadotril. Methods: This was a parallel randomised double blinded placebo controlled trial. It enrolled children between the age of 3 and 60 months of age who were admitted to hospital with severe acute gastroenteritis as evidenced by a Vesikari score of greater than 11. Children who fulfilled the criteria for inclusion were enrolled after informed consent had been obtained from their parents/guardians. They were then randomised to receive either racecadotril or placebo in addition to the standard treatment prescribed by the admitting physicians. These children were followed up daily for: the number of stools for the first 48hrs, duration of admission, duration of illness and any adverse effects noted by the accompanying parents/guardians. The results were analysed by comparing the median number of stools using the Mann Whitney test. Results: 156 children were screened, from which 120 were enrolled for the study and a final number of 58 in the placebo group and 57 in the drug group were analysed by intention to treat. There were no differences between the two groups when the numbers of stools at 48hours after introduction of